Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

GLAND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-433 Cr₹-799 Cr₹15 Cr₹35 Cr₹1,238 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Financing Activities ratio of GLAND PHARMA is ₹-433 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-433 Cr
Mar2024₹-799 Cr
Mar2023₹15 Cr
Mar2022₹35 Cr
Mar2021₹1,238 Cr

How is Cash Flow from Financing Activities of GLAND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-433 Cr
Negative
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹15 Cr
-57.25
Mar2022 ₹35 Cr
-97.18
Mar2021 ₹1,238 Cr -

Compare Cash Flow from Financing Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹26,783.3 Cr 1% -12% 2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1%

-12%

2.8%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses